Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 24,400 shares at $140.22 ($3.4M) on 2017-11-17, disclosed to the SEC on 2017-11-20.
Open-market sale of $3.4M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |